Abstract
Structures are reported here for eight further substituted N-aryl-2-chloronicotinamides, 2-ClC5H3NCONHC6H4X-4′. When X = H, compound (I) (C12H9ClN2O), the molecules are linked into sheets by N-HN, C-H(pyridyl) and C-H(arene) hydrogen bonds. For X = CH3, compound (II) (C13H11ClN2O, triclinic with Z‘ = 2), the molecules are linked into sheets by N-HO, C-HO and C-H(arene) hydrogen bonds. Compound (III), where X = F, crystallizes as a monohydrate (C12H8ClFN2O·H2O) and sheets are formed by N-HO, O-HO and O-HN hydrogen bonds and aromatic stacking interactions. Crystals of compound (IV), where X = Cl (C12H8Cl2N2O, monoclinic P21 with Z‘ = 4) exhibit inversion twinning: the molecules are linked by N-HO hydrogen bonds into four independent chains, linked in pairs by C-H(arene) hydrogen bonds. When X = Br, compound (V) (C12H8BrClN2O), the molecules are linked into sheets by N-HO and C-HN hydrogen bonds, while in compound (VI), where X = I (C12H8ClIN2O), the molecules are linked into a three-dimensional framework by N-HO and C-H(arene) hydrogen bonds and an iodoN(pyridyl) interaction. For X = CH3O, compound (VII) (C13H11ClN2O2), the molecules are linked into chains by a single N-HO hydrogen bond. Compound (VIII) (C13H8ClN3O, triclinic with Z‘ = 2), where X = CN, forms a complex three-dimensional framework by N-HN, C-HN and C-HO hydrogen bonds and two independent aromatic stacking interactions.Keywords: None Document Type: Research Article DOI: http://dx.doi.org/10.1107/S0108768106015497 Publication date: 1 de Janeiro de 2006